DiscoverBioVenture VoiCes with Chris GarabedianEpisode 21: Scion Life Sciences' Aaron Kantoff
Episode 21: Scion Life Sciences' Aaron Kantoff

Episode 21: Scion Life Sciences' Aaron Kantoff

Update: 2025-06-16
Share

Description

Aaron Kantoff describes the road on the public markets side that eventually led him to venture, and recalls successful investments he helped lead at firms like Apple Tree Partners and Medicxi, such as Stoke Therapeutics, Akero Therapeutics, Centessa Pharmaceuticals, and RayzeBio. He discusses founding Scion with his partner, Samuel Hall, and describes raising their first fund and how the firm has a longer outlook than is traditionally thought of in venture.

Comments 
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Episode 21: Scion Life Sciences' Aaron Kantoff

Episode 21: Scion Life Sciences' Aaron Kantoff

BiotechTV